These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38245383)

  • 1. Assessing deprescribing tools for implementation in care homes: A qualitative study of the views of care home staff.
    Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
    Res Social Adm Pharm; 2024 Apr; 20(4):379-388. PubMed ID: 38245383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patient's perspectives of safe and routine proactive deprescribing in primary care for older people living with polypharmacy: a qualitative study.
    Okeowo DA; Fylan B; Zaidi STR; Alldred DP
    BMC Geriatr; 2024 Oct; 24(1):844. PubMed ID: 39415136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study.
    Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
    BMJ Open; 2023 Nov; 13(11):e081305. PubMed ID: 37996237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Deprescribe Potentially Inappropriate Medications During the Hospital-to-Home Transition: Stakeholder Perspectives on Essential Tasks.
    Wang J; Shen JY; Yu F; Nathan K; Caprio TV; Conwell Y; Moskow MS; Brasch JD; Simmons SF; Mixon AS; Norton SA
    Clin Ther; 2023 Oct; 45(10):947-956. PubMed ID: 37640614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
    Mena S; Moullin JC; Schneider M; Niquille A
    BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Starting to think that way from the start": approaching deprescribing decision-making for people accessing palliative care - a qualitative exploration of healthcare professionals views.
    Robinson-Barella A; Richardson CL; Bayley Z; Husband A; Bojke A; Bojke R; Exley C; Hanratty B; Elverson J; Jansen J; Todd A
    BMC Palliat Care; 2024 Sep; 23(1):221. PubMed ID: 39242514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Willing Are Patients or Their Caregivers to Deprescribe: a Systematic Review and Meta-analysis.
    Chock YL; Wee YL; Gan SL; Teoh KW; Ng KY; Lee SWH
    J Gen Intern Med; 2021 Dec; 36(12):3830-3840. PubMed ID: 34173200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.
    Shrestha S; Giri R; Sapkota HP; Danai SS; Saleem A; Devkota S; Shrestha S; Adhikari B; Poudel A
    Ther Adv Drug Saf; 2021; 12():20420986211019309. PubMed ID: 34211689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary Care Post-graduate Trainees: a Quantitative and Qualitative Evaluation.
    Mecca MC; Thomas JM; Niehoff KM; Hyson A; Jeffery SM; Sellinger J; Mecca AP; Van Ness PH; Fried TR; Brienza R
    J Gen Intern Med; 2019 Jul; 34(7):1220-1227. PubMed ID: 30972554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
    Thorpe C; Niznik J; Li A
    BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
    Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.